Internal Medicine, Cardiovascular Disease · Boston, MA
NPI
1508069816
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
732 Harrison Ave, Preston 3rd Floor
Boston, MA, 02118
Phone (617) 638-7490
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
1,062 services
Medicare patients, 2024
623
Average age 74
Drug cost, 2024
$11.3M
1,374 prescriptions
Company payments, 2025
$198
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Omar K Siddiqi was code 93306 (echocardiography (tte/tee)), 384 times for 374 patients. In total Omar K Siddiqi billed 1,062 services in 30 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93306 Echocardiography (TTE/TEE) | Facility | 384 | 374 | $54.43 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 98 | 92 | $13.54 | $1,327 |
| 99215 Office E&M - Established | Facility | 70 | 68 | $111.97 | $7,838 |
| 99232 Hospital E&M - Subsequent | Facility | 62 | 29 | $65.70 | $4,074 |
| 93308 Echocardiography (TTE/TEE) | Facility | 54 | 40 | $20.41 | $1,102 |
| 99213 Office E&M - Established | Facility | 48 | 45 | $44.49 | $2,136 |
| 99214 Office E&M - Established | Facility | 42 | 41 | $71.32 | $2,995 |
| 99223 Hospital E&M - Initial | Facility | 40 | 38 | $143.94 | $5,758 |
| 93325 Echocardiography (TTE/TEE) | Facility | 38 | 35 | $2.45 | $93.25 |
| 93321 Echocardiography (TTE/TEE) | Facility | 37 | 34 | $5.69 | $210 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 27 | 12 | $23.82 | $643 |
| 99233 Hospital E&M - Subsequent | Facility | 26 | 18 | $98.77 | $2,568 |
| 99291 Critical Care E&M | Facility | 16 | 12 | $163.84 | $2,621 |
| 76376 CT Scan | Facility | 15 | 15 | $7.83 | $117 |
| 93312 Echocardiography (TTE/TEE) | Facility | 15 | 15 | $85.20 | $1,278 |
By year: 2022 $62K for 995 services; 2023 $57K for 870 services; 2024 $62K for 1,062 services.
Medicare prescription drug claims, 2024
In 2024, the drug Omar K Siddiqi prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 462 prescriptions and refills. In total Omar K Siddiqi wrote 1,374 Medicare prescriptions that cost $11.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 462 | 506 | 48 | $11.1M |
| Metoprolol Succinate Generic | 84 | 201 | 31 | $1,506 |
| Atorvastatin Calcium Generic | 84 | 178 | 27 | $1,021 |
| Eliquis Apixaban | 74 | 142 | 19 | $83K |
| Spironolactone Generic | 70 | 143 | 22 | $539 |
| Losartan Potassium Generic | 56 | 128 | 14 | $728 |
| Furosemide Generic | 52 | 110 | 18 | $241 |
| Torsemide Generic | 52 | 103 | 16 | $1,087 |
| Amlodipine Besylate Generic | 49 | 91 | 13 | $223 |
| Entresto Sacubitril/Valsartan | 38 | 67 | Under 11 | $43K |
| Lisinopril Generic | 34 | 90 | Under 11 | $298 |
| Carvedilol Generic | 31 | 65 | Under 11 | $566 |
| Rosuvastatin Calcium Generic | 28 | 70 | Under 11 | $800 |
| Potassium Chloride Generic | 21 | 31 | Under 11 | $329 |
| Labetalol Hcl Generic | 19 | 31 | Under 11 | $1,081 |
Brand drugs: 641 claims; generic drugs: 733 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Omar K Siddiqi $198 ($198 in general payments such as food, travel and fees) from 1 company. The largest payer was BridgeBio Pharma, Inc. with $198.
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. BBIO | 1 | $198 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.